EraCal Therapeutics
Business Services · Switzerland · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Wagistrasse 13, Schlieren, Zurich, 8952,...Website
www.eracal.chRevenue
<$5 MillionIndustry
About EraCal Therapeutics
Is EraCal Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
EraCal Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if EraCal Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if EraCal Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at EraCal Therapeutics
Click to see if EraCal Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on EraCal Therapeutics recently announced quarterly report
Product Launch: Get notified when EraCal Therapeutics launches new products
Funding: Get notified immidiatlly once EraCal Therapeutics has new funding data
Recommended Actions
Reach out to Masked Content who joined EraCal Therapeutics as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
EraCal Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
EraCal Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EraCal Therapeutics.
EraCal Therapeutics Tech Stack
A closer look at the technologies used by EraCal Therapeutics
Top Business Services Companies
Frequently Asked Questions Regarding EraCal Therapeutics
EraCal Therapeutics is a Swiss biotech company focused on developing innovative solutions for obesity and metabolic disorders. The company employs a differentiated phenotypic strategy to measure food intake and energy expenditure, targeting cardiometabolic diseases. EraCal collaborates with major industry players, including Novo Nordisk and Nestlé... Read More